Associate Professor Dr Oon Chern Ein
Associate Professor Dr. Oon Chern Ein’s dedication and passion are focused on molecular oncology, with a commitment to advancing the field through innovative research and industry partnerships. She earned her BSc (First Class Hons) in Biotechnology from Universiti Kebangsaan Malaysia and went on to complete her DPhil in Medical Oncology at the University of Oxford, United Kingdom. Dr. Oon further honed her expertise as a postdoctoral fellow at Karolinska Institutet, Sweden. Dr. Oon has been a lecturer at Universiti Sains Malaysia since 2013. She is currently a consultant for novel therapeutic projects, working with both local industries and international partners. Her work in molecular therapeutics has earned her numerous prestigious accolades, including the L’Oreal-UNESCO For Women in Science National Fellowship (2015), Women of the Future Awards (South East Asia), and the Malaysian National Young Scientist Award (2018). She was also honoured with the Promising Academician Award and Excellent Service Award from the Malaysian Ministry of Higher Education (2019), as well as the British Council Study UK Alumni Award (Professional Achievement Category) and the MINDS Women Scientist Award in 2020. Dr. Oon’s commitment to advancing the scientific community was further recognized with the Singapore Academies-ASEAN Fellowship from the Singapore National Research Foundation, which enabled her to further her expertise in drug discovery at A*STAR Singapore. Her multidisciplinary research spans drug discovery, cancer-targeted therapies, and bioengineering solutions, where she actively collaborates with industry partners. With two granted patents in Malaysia (MY-203445-A, MY-199524-A) for small molecule inhibitors targeting anti-cancer and anti-angiogenesis pathways, her work has the potential to revolutionize cancer treatment. As a member of the Global Young Academy, Dr. Oon is a strong advocate for female empowerment. Her ongoing research continues to bridge the gap between academia and industry, to transform cancer therapy through innovative and effective therapeutic strategies.
(2025)
- Xu et al. (2025) Probiotic Lactiplantibacillus plantarum Probio87 Improves Gut Microbial Profiles in HPV‐Positive Women: A Randomized, Placebo‐Controlled and Double‐Blind …, Molecular Nutrition & Food Research 69 (22), e70247
- Xu et al. (2025) Impact of the Probiotic on the Modulation of Vaginal Bacterial and Fungal Microbiota in HPV‐Positive Women, Molecular Nutrition & Food Research 69 (18), e70142
- Zhang et al. (2025) Mesua ferrea L. extract Attenuates Angiogenesis Through HIF-1α and WNT Mediated Blockage of VEGF/Angiopoietin Axis, Dose-Response 23 (3), 15593258251367613
- Xu et al. (2025) Antimicrobial and Anticancer Activities of Lactiplantibacillus plantarum Probio87 Isolated from Human Breast Milk, Nutrients 17 (15), 2554
- Xu et al. (2025) Corrigendum to: Probiotic reduces vaginal HPV abundance, improves immunity and quality of life in HPV-positive women: a randomised, placebo-controlled and double-blind study, Beneficial Microbes 16 (6), 685-686
2026 -
TFM522